Detalhe da pesquisa
1.
Renal complications of lipodystrophy: A closer look at the natural history of kidney disease.
Clin Endocrinol (Oxf)
; 89(1): 65-75, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29722904
2.
Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities.
Curr Diab Rep
; 18(12): 143, 2018 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30406415
3.
Update on Therapeutic Options in Lipodystrophy.
Curr Diab Rep
; 18(12): 139, 2018 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30370487
4.
A National Multicenter Study of Leptin and Leptin Receptor Deficiency and Systematic Review.
J Clin Endocrinol Metab
; 108(9): 2371-2388, 2023 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36825860
5.
Endogenous Leptin Concentrations Poorly Predict Metreleptin Response in Patients With Partial Lipodystrophy.
J Clin Endocrinol Metab
; 107(4): e1739-e1751, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34677608
6.
Homozygous LMNA p.R582H pathogenic variant reveals increasing effect on the severity of fat loss in lipodystrophy.
Clin Diabetes Endocrinol
; 6: 13, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32685188
7.
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
J Clin Invest
; 109(10): 1345-50, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12021250
8.
Leptin-replacement therapy for lipodystrophy.
N Engl J Med
; 346(8): 570-8, 2002 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-11856796
9.
Fatty Liver Disease, Women, and Aldosterone: Finding a Link in the Jackson Heart Study.
J Endocr Soc
; 1(5): 460-469, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29264501
10.
Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy.
Metabolism
; 72: 109-119, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28641778
11.
The spectrum of WRN mutations in Werner syndrome patients.
Hum Mutat
; 27(6): 558-67, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16673358
12.
Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy.
J Clin Endocrinol Metab
; 91(2): 621-8, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16317060
13.
Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety.
Diabetes Care
; 26(5): 1350-5, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12716787
14.
Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy.
J Clin Endocrinol Metab
; 88(6): 2821-4, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12788894
15.
Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome.
J Clin Endocrinol Metab
; 89(4): 1548-54, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15070911
16.
Intensive, long-term plasma exchange therapy for severe hypertriglyceridemia in acquired generalized lipoatrophy.
J Clin Endocrinol Metab
; 87(1): 380-4, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11788680
17.
Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy.
J Clin Endocrinol Metab
; 87(7): 3110-7, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12107209
18.
Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy.
J Clin Endocrinol Metab
; 89(7): 3199-207, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15240593
19.
Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.
J Clin Endocrinol Metab
; 88(10): 4840-7, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14557463
20.
Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective.
Medicine (Baltimore)
; 83(4): 209-222, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15232309